NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
Clinical Trials
14 trialsNCT06334120 2026-03-12
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Bayer
Recruiting
NCT06724159 2026-02-17
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
Recruiting
NCT07406282 2026-02-12
Double-DARE
Bayer
Recruiting
NCT07344779 2026-01-26
ROAD
Bayer
Not yet recruiting
NCT07181122 2025-11-24
PRO-MIND
Ankara Etlik City Hospital
Recruiting
NCT05202301 2025-08-11
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
Bayer
Completed
NCT06013475 2025-06-12
DEAR-EXT
Bayer
Completed
NCT06652607 2025-03-12
PSA-DEEP02
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05612880 2025-01-09
Physical Function During ARSI Treatment
UNC Lineberger Comprehensive Cancer Center
Completed
NCT06498921 2024-10-24
BELBEQA
Bayer
Completed
NCT06435702 2024-05-30
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Peking University Third Hospital
Not yet recruiting
NCT06430411 2024-05-28
OLIGOMET
Medical University of Vienna
Not yet recruiting
NCT05362149 2024-03-20
DEAR
Bayer
Completed